News About: Pharm. Industry
What are major issues for the 2nd year half in Korean drug market?
Korea must be careful regarding exporting pharmaceutical products this year due to various aspects such as nullification of the Ecuadorian drug agreement and Indonesian ‘Protectionism.’
The KOTRA(Korea Trade-Investme...
Daewoong Pharmaceutical extends business in Vietnam in cooperation with Top 2 Vietnamese pharma ‘Traphaco’
Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced Branch Manager Dong-Hyu kim and an employee at a Vietnamese branch of Daewoong Pharmaceutical were appointed as member of board of directors and board of supervisor...
GC Pharm cruising to commercialize flu vaccine for the elderly
GC Pharm has gotten a step closer to commercializing influenza vaccines that are more effective with the elderly.
GC Pharm(CEO Eun-Cheol Huh) announced on the 26th that they acquired approval of Phase II clinical tri...
Samsung Biologics acquires drug product manufacturing approval from U.S. FDA
Samsung Biologics(CEO Tae-Han Kim) announced on the 25th that they acquired manufacturing approval of its first finished drug product from the Food and Drug Administration, a federal agency of the United States Depart...
GOODTCELLS succeeds in attracting KRW 5 billion from Yuhan Corporation
GOODTCELLS, a biopharmaceutical venture specializing in immune disorder therapies, announced on the 23rd that the company succeeded in attracting a KRW 5 billion investment from Yuhan Corporation(CEO Jung-Hee Lee).
Y...
Pharma industry’s concern on MFDS’s investigation on Indian ingredients
Pharmaceutical companies have been extremely worried because the Chinese Valsartan ingredient incident has not been finalized by ‘product recall,’ but led to extensive investigation.
According to the pharmaceutical i...
What are requirements for hospitalization specialists? They are ‘money’ and ‘identity’
While the hospitalization specialist system has drawn positive results at its demo project, ‘money’ and ‘identity’ are reportedly required to adopt the system.
Despite high possibility for the system to enhance the n...
A series of gene therapies expected to be commercialized with 65 clinical trials
It seems a series of products will be commercialized as the Ministry of Food and Drug Safety(MFDS) approved 65 cases of clinical trials for gene therapy development.
The MFDS approved Kolon Life Science’s ‘Invossa K...
Handok officially launches hangover relief ‘READY-Q’ in China
Handok(Chairman Young-Jin Kim) officially launches hangover relief ‘READY-Q’ in China.
Handok announced they completed shipping a large amount of products, 120 thousand ‘READY-Q Drink’ products and 77 thousand ‘READ...
Samyang Biopharmaceuticals working on opening a branch in world’s biopharmaceutical center Boston
Samyang Biopharmaceuticals will open a new branch in Boston, USA.
According to the company, Samyang Biopharmaceuticals is planning to open a branch in Boston this August; later, it will discover new drug and biologi...
